-
Hypoxia and Immunometabolism in Tumors
2026-09-07
The 2025 Cancer Letters review presents tumor hypoxia and immune metabolism as a reciprocal system linking oxygen limitation, nutrient competition, metabolic reprogramming, and immune suppression. Its main practical contribution is a framework for designing metabolism-focused tumor studies while identifying why hypoxia- and immunometabolism-targeted therapies may be difficult to translate.
-
TCEP Hydrochloride: Mechanism and Workflow
2026-09-07
Tris(2-carboxyethyl) phosphine hydrochloride, also called TCEP hydrochloride, is a thiol-free, water-soluble reagent for disulfide bond reduction. Its documented uses include protein digestion enhancement, hydrogen-deuterium exchange analysis, dehydroascorbic acid reduction, and selected organic synthesis workflows.
-
EdU Flow Cytometry Assay Kits: Cell Crosstalk
2026-09-05
EdU Flow Cytometry Assay Kits (Cy3) can convert intercellular signaling into a quantitative S-phase readout. This article explains how the K1077 assay can strengthen hypoxia pulmonary hypertension models by separating DNA replication measurement from apoptosis, cell identity, and pathway-specific interpretation.
-
Candida krusei Phases Trigger Distinct Apoptosis
2026-09-04
Miao and colleagues show that the yeast and hypha phases of Candida krusei induce bovine mammary epithelial-cell apoptosis through different dominant pathways. The study links yeast-associated injury to mitochondrial signaling, hypha-associated injury to death ligand/receptor signaling, and both responses to TLR2/ERK and JNK/ERK regulation, providing a framework for phase-specific studies of fungal mastitis.
-
JZL184: MAGL Inhibition in Pain Research
2026-09-04
JZL184 is a selective monoacylglycerol lipase inhibitor for connecting 2-AG metabolism with synaptic, nociceptive, and affective readouts. This workflow-focused guide shows how to prepare the compound, validate CB1-dependent effects, and avoid common lipidomics, electrophysiology, and behavioral assay confounders.
-
Angiotensin II A1042: Practical Research Protocol
2026-09-03
This guide outlines how to prepare and apply Angiotensin II (SKU A1042) in receptor, vascular cell, and vascular remodeling workflows. It distinguishes dossier-supported parameters from laboratory recommendations and identifies where model-specific validation is required; the product is for research use only, not diagnostic or therapeutic use.
-
WP1066: Mapping JAK2/STAT3 Across Cancer and Repair
2026-09-03
WP1066 is a cell-permeable JAK2/STAT3 inhibitor for testing pathway dependence in cancer models, including renal carcinoma and AML. This thought-leadership guide connects its oncology applications with emerging evidence that JAK2-STAT3 signaling also regulates macrophage metabolism and bone regeneration, while defining the limits of cross-domain translation.
-
Lipo3K Transfection Reagent for Resistance Biology
2026-09-02
Explore how Lipo3K Transfection Reagent can support mechanistic studies of paclitaxel resistance, ABC transporter biology, and cholesterol-rich membrane domains. This article presents a causal assay framework rather than another general transfection guide, integrating nucleic acid delivery with rigorous interpretation of cancer-cell phenotypes.
-
LBP, AMPK, and Mitophagy in Skeletal Muscle
2026-09-02
A 2025 study shows that Lycium barbarum polysaccharide alleviates high-fat-diet-associated skeletal muscle atrophy by linking AMPK activation to PINK1/Parkin-mediated mitophagy. Its combined mouse and palmitate-stressed cell models provide mechanistic evidence that improving mitochondrial quality control can also normalize glucose and lipid disturbances in sarcopenic obesity.
-
n-Dodecyl-β-D-maltoside: Assay Design Guide
2026-09-01
Learn how n-Dodecyl-β-D-maltoside (DDM) can be selected and controlled as an experimental variable in membrane-protein purification, folding, and activity assays. Using WecA as a case study, this guide connects detergent chemistry with assay validity rather than treating solubilization as a standalone step.
-
Hepatic sEH–Nrf2 Signaling in Osteoporosis
2026-09-01
A 2025 study identifies a liver–bone axis in which hepatic soluble epoxide hydrolase alters circulating 14,15-EET and 14,15-DHET, suppresses Nrf2–ARE signaling, and promotes osteoclastogenesis. By combining clinical samples, an ovariectomy-induced mouse model, liver-specific knockdown, pharmacological inhibition, and transcriptomics, the work links fatty acid epoxide signaling to redox control of bone remodeling.
-
Neomycin sulfate for Mechanistic Research
2026-08-31
Neomycin sulfate is an aminoglycoside antibiotic used as a mechanistic probe for RNA/DNA structures, HIV-1 Tat–TAR binding, and ryanodine receptor function. This guide connects those assays with microbiome–immune study design while emphasizing practical preparation, controls, and troubleshooting.
-
Blebbistatin for Spatial Cell Mechanics Assays
2026-08-31
Explore how (±)-Blebbistatin can turn cell imaging into a spatially resolved test of non-muscle myosin II function. This article adapts principles from panoramic cardiac mapping to improve causal interpretation of migration, adhesion, and morphology assays.
-
n-Dodecyl-β-D-maltoside for Integrin Cryo-EM
2026-08-30
n-Dodecyl-β-D-maltoside (DDM) offers a gentle route to solubilize and stabilize full-length membrane receptors while preserving conformational heterogeneity for cryo-EM and functional assays. This workflow translates recent αvβ3 structural insights into practical detergent screens, sample-quality checks, and troubleshooting decisions.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-08-29
The reference study introduced monocyte-derived dendritic cells as a carrier for fluorescently labeled amikacin, using their pathogen-responsive trafficking to deliver antibiotic cargo into Mycobacterium avium granulomas in mice. Its findings support a preclinical strategy for increasing local drug exposure while reducing reliance on high systemic aminoglycoside concentrations, but they do not yet establish therapeutic efficacy or clinical safety.